Centers

Weccome Centre for Anti-Infectives Research

FDA Oncology Center of Excellence Project Catalyst

UCSC Chemical Screening Center

WCAIR brings together the Drug Discovery Unit (DDU) , the Mode of Action group and the Parasitology research groups. With the daily interactions of these groups, parasitology and drug discovery can work together in synergy. This empowers us to create...
Read more

Providing a regulatory platform to connect scientific knowledge, creative insight, and medical professionals to foster early-stage product innovation

Read more

We are a shared research facility dedicated to improving human health by finding therapeutic agents against a wide variety of diseases, dedicated to advancing scientific knowledge and technologies, and dedicated to education of the next generation of...

Read more

Partnerships

Events

Jobs

Argenta and ANTABIO Announce Drug Discovery Collaboration

Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, announced today that it has achieved a milestone with its collaboration partner Antabio in an anti-bacterial drug...

 
View all

CEO

development of peptide therapeutics to metastatic cancer

 
View all

Johns Hopkins BSi Licenses GCPII Assets from Eisai

Johns Hopkins Brain Science Institute ("BSi") has taken a non-exclusive license from Eisai to develop new compounds related to Glutamate Carboxypeptidase II (GCP-II) technology. The new compounds developed under this license will be targeted...

 
View all

No EVENTS for listing

No Job Posts

Sponsors

Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins Pfizer Roche HL Tocris Sigma-Aldrich Xenotech Xenotech Eurofins
View All